Table 2.
Phospho-GSKα/β (Ser9/21) localization in benign cystadenomas, borderline tumors, and cystadenocarcinomas
| Phospho-GSKα/β | Localization
|
P | Total No. Cores | ||
|---|---|---|---|---|---|
| Polarized | Diffuse | Mixed | |||
| Benign | 23 | 55 | 11 | <0.0001 (Benign/borderline) | 89 |
| Borderline | 4 | 89 | 9 | 0.002 (Borderline/carcinoma) | 102 |
| Cystadenocarcinoma | 0 | 91 | 0 | <0.0001 (Benign/carcinoma) | 91 |
Localization of phospho-GSK immunostaining was scored for each tissue core. Polarized, staining predominantly at the terminal bar. Diffuse, diffuse cytoplasmic staining. Mixed, combination of diffuse and polarized staining. Differences in phospho-GSK localization between tissue categories were analyzed using χ-square test.